TSX Penny Stocks With Market Caps Under CA$200M
As we head into the second half of 2025, the Canadian market is navigating a landscape shaped by ongoing tariff and trade negotiations, which could influence economic growth and inflation. Despite these uncertainties, the potential for positive economic growth remains, especially as both Canada and the U.S. are largely service-driven economies. In this context, penny stocks—often representing smaller or newer companies—continue to be an intriguing investment area due to their potential for significant returns when backed by strong financial health.
Name
Share Price
Market Cap
Financial Health Rating
PetroTal (TSX:TAL)
CA$0.69
CA$640.24M
★★★★★☆
Orezone Gold (TSX:ORE)
CA$1.24
CA$665.6M
★★★★★☆
Dynacor Group (TSX:DNG)
CA$4.40
CA$189.71M
★★★★★★
Findev (TSXV:FDI)
CA$0.445
CA$12.6M
★★★★★★
Thor Explorations (TSXV:THX)
CA$0.77
CA$518.93M
★★★★★★
Automotive Finco (TSXV:AFCC.H)
CA$0.89
CA$17.44M
★★★★★★
NTG Clarity Networks (TSXV:NCI)
CA$2.26
CA$98.22M
★★★★★★
Intermap Technologies (TSX:IMP)
CA$2.19
CA$125.23M
★★★★★☆
Hemisphere Energy (TSXV:HME)
CA$1.95
CA$185.99M
★★★★★★
McChip Resources (TSXV:MCS)
CA$1.00
CA$5.65M
★★★★★★
Click here to see the full list of 890 stocks from our TSX Penny Stocks screener.
Let's take a closer look at a couple of our picks from the screened companies.
Simply Wall St Financial Health Rating: ★★★★★★
Overview: Psyched Wellness Ltd. is a health supplements company that produces and distributes mushroom-derived products and related consumer packaged goods in the United States, with a market cap of CA$8.66 million.
Operations: The company generates revenue from its Vitamins & Nutrition Products segment, amounting to CA$0.64 million.
Market Cap: CA$8.66M
Psyched Wellness Ltd. is a pre-revenue company with CA$0.64 million in sales, facing auditor concerns about its ability to continue as a going concern. Despite having no debt and sufficient short-term assets (CA$6.7M) to cover liabilities (CA$234.9K), it remains unprofitable with increasing losses over the past five years at 14.7% annually. The stock's volatility is high, yet stable compared to previous periods, and shareholders have not faced significant dilution recently. A recent pilot for a new dietary supplement may offer future revenue potential if successful in consumer testing and market launch preparations are completed effectively.
Unlock comprehensive insights into our analysis of Psyched Wellness stock in this financial health report.
Review our historical performance report to gain insights into Psyched Wellness' track record.
Simply Wall St Financial Health Rating: ★★★★☆☆
Overview: Sailfish Royalty Corp. focuses on acquiring precious metals royalty and streaming agreements, with a market cap of CA$185.49 million.
Operations: The company generates revenue of $3.07 million from its royalties and stream interests.
Market Cap: CA$185.49M
Sailfish Royalty Corp. has a market cap of CA$185.49 million and is not pre-revenue, with US$0.59 million in revenue for Q1 2025 despite a net loss of US$0.075 million compared to the previous year's profit. The company benefits from its 2% net smelter return royalty on Mako Mining's El Golfo area, where promising drill results have been reported, potentially enhancing future cash flows and resource expansion opportunities. While Sailfish's earnings grew significantly last year, its forecasted decline in earnings presents a challenge alongside limited interest coverage by EBIT and dividends not well covered by earnings or free cash flow.
Click here to discover the nuances of Sailfish Royalty with our detailed analytical financial health report.
Understand Sailfish Royalty's earnings outlook by examining our growth report.
Simply Wall St Financial Health Rating: ★★★★★☆
Overview: NeoTerrex Minerals Inc. is involved in the evaluation, acquisition, and exploration of mineral properties in Canada with a market cap of CA$14.96 million.
Operations: NeoTerrex Minerals Inc. does not currently report any revenue segments.
Market Cap: CA$14.96M
NeoTerrex Minerals Inc., with a market cap of CA$14.96 million, is pre-revenue and focuses on mineral exploration in Canada. The company has no debt and maintains a cash runway exceeding one year under stable conditions. Recent announcements highlight fully-funded exploration plans targeting rare earth elements across several projects, including Mount Discovery and Galactic REE projects, leveraging favorable tax incentives. Despite its unprofitability, NeoTerrex's strategic focus on critical minerals positions it for potential future value creation pending successful exploration outcomes. However, the stock remains highly volatile with significant price fluctuations observed recently.
Navigate through the intricacies of NeoTerrex Minerals with our comprehensive balance sheet health report here.
Explore historical data to track NeoTerrex Minerals' performance over time in our past results report.
Click through to start exploring the rest of the 887 TSX Penny Stocks now.
Ready To Venture Into Other Investment Styles? AI is about to change healthcare. These 22 stocks are working on everything from early diagnostics to drug discovery. The best part - they are all under $10b in market cap - there's still time to get in early.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
Companies discussed in this article include CNSX:PSYC TSXV:FISH and TSXV:NTX.
This article was originally published by Simply Wall St.
Have feedback on this article? Concerned about the content? with us directly. Alternatively, email editorial-team@simplywallst.com
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Business Upturn
an hour ago
- Business Upturn
LEADING EDGE MATERIALS REPORTS QUARTERLY RESULTS TO APRIL 30, 2025
By GlobeNewswire Published on June 21, 2025, 02:30 IST LEADING EDGE MATERIALS REPORTS QUARTERLY RESULTS TO APRIL 30, 2025 Vancouver, June 20, 2025 – Leading Edge Materials Corp. ('Leading Edge Materials' or the 'Company') (TSXV: LEM) (Nasdaq First North: LEMSE) (OTCQB: LEMIF) (FRA: 7FL) announces results for the fiscal period ending April 30, 2025. All references to dollar amounts in this release are in Canadian dollars. Highlights During and After the Quarter During the three months ended April 30, 2025: • On February 9, 2025, the Company provided an update on a Rapid Development Plan ('RDP') for Norra Kärr, to be in production in the shortest possible timeframe, supplying HREE-rich eudialyte concentrate and industrial mineral nepheline syenite. • The Company provided an update on the value creation options being considered for Woxna Graphite, on February 16, 2025, including a possible restart of operations, the production of high-quality flake graphite concentrate. • On March 23, 2025, the Company provided a progress update on Norra Kärr, in the context of the European Commission's ('EC') Joint White Paper for European Readiness 2030, highlighting the increasing geopolitical competition over critical raw materials ('CRMs') and the need for the EU and its member states to build strategic reserves of raw materials. • On March 25, 2025, the EU announced its first list of Strategic Projects under the Critical Raw Materials Act ('CRMA'); Norra Kärr was not included. The Company stated its plan to reapply in the next round of applications. • On April 23, 2025, the Company announced granting of stock options (the 'Options') to directors, officers and consultants of the Company to purchase an aggregate of 6,850,000 common shares (the 'Optioned Shares') of the Company, at exercise price of C$0.24 per Optioned Share, expiring on the date that is 5 years from the date of grant for directors and officers and three years from the date of grant for consultants. The Options will vest 33% on the date of the grant, 33% one year after the date of grant and 34% two years after the date of grant. The Options were issued pursuant to the terms of the Company's Option Plan. Results of Operations Three Months Ended April 30, 2025, Compared to Three Months Ended January 31, 2025 During the three months ended April 30, 2025 ('Q2 2025') the Company reported a net loss of $1,179,168 compared to a reported net loss of $669,216 for the three months ended January 31, 2025 ('Q1 2025'), an increase in loss by $509,952, the increase in loss mainly due to share based compensation expenses of $585,529 (Q1 2025 – $129,292) and foreign exchange loss of $117,063 (Q1 2025 – gain $1,690). Three Months Ended April 30, 2025, Compared to Three Months Ended April 30, 2024 During the three months ended April 30, 2025 ('2025 period'), the Company reported a net loss of $1,179,168 compared to a net loss of $859,529 for the three months ended April 30, 2024 ('2024 period'), an increase in loss of $319,639, the increase in loss mainly due to share based compensation expenses of $585,529 (Q2 2024 – $349,923) and foreign exchange loss of $117,063 (Q2 2024 – $5,754). Selected Financial Data The following selected financial information is derived from the unaudited condensed consolidated interim financial statements of the Company prepared in accordance with IFRS. Fiscal 2025 Fiscal 2024 Fiscal 2023 Three Months Ended April 30,2025 $ January 31,2025 $ October 31,2024 $ July 31,2024 $ April 30,2024 $ January 31,2024 $ October 31,2023(Restated) $ July 31,2023(Restated) $ Operations Expenses (1,070,402) (696,037) (97,209) (797,070) (863,745) (660,617) (457,890) (309,832) Other items (108,766) 26,821 (222,820) (25,168) 4,216 (25,311) 195,209 (8,442) Comprehensive profit/(loss) (1,179,168) (669,216) (320,029) (822,238) (859,529) (685,928) (262,681) (318,274) Basic Profit/(loss) per share (0.01) (0.00) (0.00) (0.00) (0.01) (0.00) (0.00) (0.00) Diluted profit/(loss) per share (0.01) (0.00) (0.00) (0.00) (0.01) (0.00) (0.00) (0.00) Financial Position Working capital 1,191,514 2,198,641 3,337,686 3,973,458 1,610,635 2,316,098 2,713,098 848,952 Total assets 28,361,774 28,480,311 29,343,716 28,454,783 24,991,481 26,003,943 25,512,111 23,588,662 Total non-current liabilities (6,009,933) (5,596,369) (5,641,854) (5,683,545) (5,101,289) (5,489,843) (4,670,790) (5,109,575) Financial Condition / Capital Resources During the three months ended April 30, 2025, the Company recorded a net loss of $1,179,168 and, as of April 30, 2025, the Company had an accumulated deficit of $51,201,042 and working capital of $1,191,514. The Company maintains its Woxna Graphite mine in a 'production-ready' basis while minimizing costs. The Company is also evaluating a potential restart of flake graphite concentrate production. The Company anticipates that it has sufficient funding to meet anticipated levels of corporate administration and overheads for the ensuing twelve months however, it will need additional capital to provide working capital and recommence operations at the Woxna Graphite, to fund future development of the Norra Kärr project or to complete exploration activities in Romania. There is no assurance such additional capital will be available to the Company on acceptable terms or at all. In the longer term the recoverability of the carrying value of the Company's long-lived assets is dependent upon the Company's ability to preserve its interest in the underlying mineral property interests, the discovery of economically recoverable reserves, the achievement of profitable operations and the ability of the Company to obtain financing to support its ongoing exploration programs and mining operations. Outlook Concerns about critical raw materials – security of supply, supply chain resilience and defence requirements – have been recurring themes at conferences attended by the Company in recent months, with HREEs and natural graphite frequently mentioned; geopolitical uncertainties continue, with more talk about the weaponization of global trade in rare earth elements. On June 17, 2025, the G7 Critical Minerals Action Plan was announced focused on 'diversifying the responsible production and supply of critical minerals, encouraging investments in critical mineral projects and local value creation, and promoting innovation' in the G7, and with partners beyond, working together and 'to swiftly protect our economic and national security''. Against this backdrop and calls for more action to match the intent of the CRMA, the Company's portfolio is well positioned. Woxna Graphite Mine The Company maintains the Woxna Graphite Mine in a production-ready state while minimizing holding costs. An internal study completed in early 2022 assessed the potential for restarting operations and upgrading the processing plant to produce high-quality flake graphite concentrate. Work is now underway to update this study, forming the basis of a business plan to support possible project financing, customer prepayments, and access to Swedish or EU public funding, and, in addition. Highlighting Sweden's role in CRMs and graphite's importance, Sweden's Energy, Business and Industry Minister Ebba Busch recently stated that 'Sweden has unique opportunities to be and remain a strong player in global mineral politics. We have the most sustainable mining industry in the world – ethically sustainable, environmentally sustainable, and with good working conditions. The graphite that [Talga Group] is planning to produce is a key material in battery manufacturing and the green transition to a fossil-fuel-free society.' Norra Kärr Heavy Rare Earth Element ('HREE') Project As part of its Pre-feasibility ('PFS') workstreams, the Company is developing a Rapid Development Plan ('RDP') for Norra Kärr to enable the earliest possible production of HREE-rich eudialyte concentrate and industrial mineral nepheline syenite. A phased, small-scale start is under consideration to allow early access to the deposit, initial sales of nepheline syenite, early cash flow, and stockpiling of eudialyte concentrate for future processing. This approach is designed to reduce both risk and environmental impacts. Testwork has now been completed on nepheline syenite and aegirine to determine their mineralogy, chemical composition, and leachate chemistry. The promising results are being used to determine possible market segments and specifications that can be achieved, potential demand and pricing, to be included in an updated PFS economic model for Norra Kärr. The Company envisages the PFS will be completed in Q1 2026. On 24 March 2025, the EU announced its first list of Strategic Projects under the Critical Raw Materials Act (CRMA); Norra Kärr was not included. The Company plans to reapply in the next round of applications having continued to make significant progress since the last application was submitted in August 2024. In recent months, the Company's application for a new Exploitation Concession ('Bearbetningskoncession') 25-year mining lease has been out for consultation with County Administrative Boards ('CAB') and municipalities. The Company understands that CAB opinions have been received by the Mining Inspectorate ('Bergsstaten'). The Company will have an opportunity to respond to opinions and comments. Bihor Sud Nickel-Cobalt Exploration Project Exploration activities at the Bihor Sud project have continued, supported by the hard work of the four new geologists who joined the team in January. Works have included underground mapping, diamond drilling, geophysics, core logging, and sampling. The Company's goal remains to define a large-scale, mineable mineral resource; in gallery G2, targeting promising Zinc-Lead-Copper-Silver mineralization. Results to date are encouraging and underscore the project's strong potential for a significant polymetallic discovery. Financial Information The report for three months ending July 31, 2025, is expected to be published on or about September 19, 2025. On behalf of the Board of Directors, Leading Edge Materials Corp. Kurt Budge, CEO For further information, please contact the Company at: [email protected] Follow usTwitter: Linkedin: About Leading Edge Materials Leading Edge Materials is a Canadian public company focused on developing a portfolio of critical raw material projects located in the European Union. Critical raw materials are determined as such by the European Union based on their economic importance and supply risk. They are directly linked to high growth technologies such as lithium-ion batteries and permanent magnets for electric motors, wind turbines and defense applications. The portfolio of projects includes the 100% owned Woxna Graphite mine (Sweden), 100% owned Norra Kärr Heavy Rare Earth Elements project (Sweden), and the 51% owned Bihor Sud Nickel Cobalt exploration alliance (Romania). Additional Information The information was submitted for publication through the agency of the contact person set out above, on June 20, 2025, at 2:30 PM Vancouver time. Leading Edge Materials is listed on the TSXV under the symbol 'LEM', OTCQB under the symbol 'LEMIF' and Nasdaq First North Stockholm under the symbol 'LEMSE'. Svensk Kapitalmarknadsgranskning ('SKMG') is the Company's Certified Adviser for the Nasdaq First North Growth Market (Stockholm) and may be contacted via email [email protected] or by phone +46 (0)8 913 008. Reader Advisory This news release may contain statements which constitute 'forward-looking information', including statements regarding the plans, intentions, beliefs and current expectations of the Company, its directors, or its officers with respect to the future business activities of the Company. The words 'may', 'would', 'could', 'will', 'intend', 'plan', 'anticipate', 'believe', 'estimate', 'expect' and similar expressions, as they relate to the Company, or its management, are intended to identify such forward-looking statements. Investors are cautioned that any such forward-looking statements are not guarantees of future business activities and involve risks and uncertainties, and that the Company's future business activities may differ materially from those in the forward-looking statements as a result of various factors, including, but not limited to, fluctuations in market prices, changes in the Company's intended use of proceeds from the Private Placement, successes of the operations of the Company, continued availability of capital and financing and general economic, market or business conditions. There can be no assurances that such information will prove accurate and, therefore, readers are advised to rely on their own evaluation of such uncertainties. The Company does not assume any obligation to update any forward-looking information except as required under the applicable securities laws. Neither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accept responsibility for the adequacy or accuracy of this news release. Attachments LEM – News Release Financial Results – April 30, 2025 Financial Report Disclaimer: The above press release comes to you under an arrangement with GlobeNewswire. Business Upturn takes no editorial responsibility for the same. Ahmedabad Plane Crash GlobeNewswire provides press release distribution services globally, with substantial operations in North America and Europe.
Hamilton Spectator
2 hours ago
- Hamilton Spectator
High Arctic Announces Annual General and Special Meeting Results
NOT FOR DISTRIBUTION TO U.S. NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES. ANY FAILURE TO COMPLY WITH THIS RESTRICTION MAY CONSTITUTE A VIOLATION OF U.S. SECURITIES LAW CALGARY, Alberta, June 20, 2025 (GLOBE NEWSWIRE) — High Arctic Energy Services Inc. (TSX: HWO) (the 'Corporation' or 'High Arctic') is pleased to announce the results of the annual general and special meeting of the shareholders of High Arctic held on June 19, 2025 (the 'Meeting'). 32 shareholders holding a total of 8,570,252 common shares of the Corporation were represented at the Meeting in person or proxy, representing approximately 67.50% of the total votes attached to all issued and outstanding common shares of the Corporation as of the record date on May 12, 2025. All matters put forth at the Meeting were approved. In respect of the election of directors, the shareholders approved fixing the number of directors at four with each nominee named in the Corporation's management information circular dated May 26, 2025 being considered for election as directors. The detailed results of the vote for the election of directors, which was conducted by ballot, are set out below: At the Meeting, the shareholders also approved a resolution appointing MNP LLP, Chartered Professional Accountants, as auditors of the Corporation and a resolution approving a new omnibus equity incentive plan of the Corporation, to replace the existing stock option plan, performance share unit plan, and deferred share unit plan. About High Arctic Energy Services High Arctic is an energy services provider. High Arctic provides pressure control equipment and equipment supporting the high-pressure stimulation of oil and gas wells and other oilfield equipment on a rental basis to exploration and production companies, from its bases in Whitecourt and Red Deer, Alberta. For further information contact: Lonn Bate Chief Financial Officer P: 587-318-2218 P: +1 (800) 688 7143 High Arctic Energy Services Inc. Suite 2350, 330 – 5th Ave SW Calgary, Alberta, Canada T2P 0L4 website: Email: info@
Business Wire
2 hours ago
- Business Wire
SINOVAC Board of Directors Prevails Against Advantech/Prime's New York Lawsuit
BEIJING--(BUSINESS WIRE)--SINOVAC Biotech Ltd. (NASDAQ: SVA) (' SINOVAC ' or the ' Company '), a leading provider of biopharmaceutical products in China, today announced it has prevailed against Advantech/Prime Success' ('Advantech/Prime') Petition for Emergency Injunctive Relief in the U.S. District Court for the Southern District of New York. The result in the New York court represents another failure in the campaign by Advantech/Prime in coordination with Vivo Capital (together known as the 'Dissenting Investor Group') to wrest control of SINOVAC from its recently installed, lawfully-elected Board of Directors (the 'current SINOVAC Board') in accordance with the Privy Council order and Antiguan Law, and to interfere with the payment of the US$55.00 per common share special cash dividend declared by the current SINOVAC Board. Following the New York court's ruling, the current SINOVAC Board is free to pursue its legal action in Antigua seeking to cancel the PIPE shares invalidly issued to the Dissenting Investor Group by the former illegitimate board (the 'Imposter Former Board'). If the current SINOVAC Board succeeds in legal proceedings on the PIPE shares, it has announced its intention to redistribute an additional US$11.00 per common share to SINOVAC's valid shareholders. Dr. Chiang Li, Chairman of the SINOVAC Board, commented, 'We will continue our mission to restore fairness and deliver value to all valid SINOVAC shareholders, starting with paying the $55.00 per share special cash dividend as soon as July 7, 2025.' The Dissenting Investor Group's self-serving, multi-pronged lawfare strategy against SINOVAC has one goal: to prevent all valid SINOVAC common shareholders from receiving any dividend payments unless the Dissenting Investor Group receives an allocation for their invalid PIPE shares, despite the fact that they have already received over US$1 billion in dividends from a SINOVAC operating subsidiary. The current SINOVAC Board has set aside in escrow the pro rata portion of dividends for the PIPE shares — funds the Dissenting Investor Group could receive if the legal proceedings they initiated rule in their favor. The current SINOVAC Board is fighting back – and winning. We feel certain that we will prevail against any further legal action by the Dissenting Investor Group and look forward to ensuring all valid shareholders receive their fair share. Your Vote is Important Your vote on or before July 8 will be about the future of SINOVAC, your receipt of your make-whole dividend payments in the near-term, and the long-term value of your investment. We urge you to keep SINOVAC's Board in place and vote on the WHITE proxy card ' AGAINST ' Proposal 1 to remove the current Board and ' AGAINST ' Proposal 2 to appoint the Reconstituted Imposter Board Slate. Your vote is critical to ensuring that SINOVAC remains on the path to stability, growth, and value creation for all shareholders. DISCARD any items you received asking you to vote for the Reconstituted Imposter Former Board Slate. If you have already voted for the Reconstituted Imposter Former Board Slate, you can subsequently revoke it by using the WHITE proxy card or WHITE voting instruction form to vote. Only your latest-dated vote will count! If you have questions about how your vote can be counted, please contact our proxy solicitor, Georgeson LLC, toll free at (844) 568-1506 in the U.S. and (646) 543-1968 outside the U.S. or via email at SinovacSpecialMeeting@ About SINOVAC Sinovac Biotech Ltd. (SINOVAC) is a China-based biopharmaceutical company that focuses on the R&D, manufacturing, and commercialization of vaccines that protect against human infectious diseases. SINOVAC's product portfolio includes vaccines against COVID-19, enterovirus 71 (EV71) infected Hand-Foot-Mouth disease (HFMD), hepatitis A, varicella, influenza, poliomyelitis, pneumococcal disease, etc. The COVID-19 vaccine, CoronaVac®, has been approved for use in more than 60 countries and regions worldwide. The hepatitis A vaccine, Healive®, passed WHO prequalification requirements in 2017. The EV71 vaccine, Inlive®, is an innovative vaccine under "Category 1 Preventative Biological Products" and commercialized in China in 2016. In 2022, SINOVAC's Sabin-strain inactivated polio vaccine (sIPV) and varicella vaccine were prequalified by the WHO. SINOVAC was the first company to be granted approval for its H1N1 influenza vaccine Panflu.1®, which has supplied the Chinese government's vaccination campaign and stockpiling program. The Company is also the only supplier of the H5N1 pandemic influenza vaccine, Panflu®, to the Chinese government stockpiling program. SINOVAC continually dedicates itself to new vaccine R&D, with more combination vaccine products in its pipeline, and constantly explores global market opportunities. SINOVAC plans to conduct more extensive and in-depth trade and cooperation with additional countries, and business and industry organizations. Important Additional Information and Where to Find It In connection with SINOVAC's Special Meeting, SINOVAC has filed with the U.S. Securities and Exchange Commission ('SEC') and mailed to shareholders of record entitled to vote at the Special Meeting a definitive proxy statement and other documents, including a WHITE proxy card. SHAREHOLDERS ARE ENCOURAGED TO READ THE PROXY STATEMENT AND ALL OTHER RELEVANT DOCUMENTS WHEN FILED WITH THE SEC AND WHEN THEY BECOME AVAILABLE BECAUSE THOSE DOCUMENTS WILL CONTAIN IMPORTANT INFORMATION. Investors and other interested parties will be able to obtain the documents free of charge at the SEC's website, or from SINOVAC at its website: You may also obtain copies of SINOVAC's definitive proxy statement and other documents, free of charge, by contacting SINOVAC's Investor Relations Department at ir@ Safe Harbor Statement This announcement contains forward-looking statements within the meaning of Section 21E of the Securities Exchange Act of 1934, as amended, and as defined in the U.S. Private Securities Litigation Reform Act of 1995. These forward-looking statements can be identified by terminology such as 'may,' 'will,' 'expect,' 'anticipate,' 'aim,' 'estimate,' 'intend,' 'plan,' 'believe,' 'potential,' 'continue,' 'is/are likely to' or other similar expressions. Such statements are based upon current expectations and current market and operating conditions and relate to events that involve known or unknown risks, uncertainties and other factors, all of which are difficult to predict and many of which are beyond the Company's or Board's control, which may cause actual results, performance or achievements to differ materially from those in the forward-looking statements. Further information regarding these and other risks, uncertainties or factors is included in the Company's filings with the U.S. Securities and Exchange Commission. The Company and Board do not undertake any obligation to update any forward-looking statement as a result of new information, future events or otherwise, except as required under law.
